Funding Decisions |
     |
Overview of previous funding rounds:
Rounds: 7 | 6 | 5 | 4 | 3 | 2 | 1
 |
Overview of previous funding waves:
Waves: 1 | 2 | 3 |
|
Following the review of seven proposal rounds:
Round 7 - November 2007
| Total | Total approved US$ 1,119 million 73 programs in 66 countries/economies* | ||
| By Region | East Asia & the Pacific - US$ 92 million for 11 programs in 19 countries/ economies* |
||
| By Disease | HIV US$ 537 million for 26 programs in 39 countries/economies* Malaria US$ 471 million for 28 programs in 27 countries/economies Tuberculosis US$ 111 million for 19 programs in 30 countries/economies* |
||
| Documentation |
|
||
| *Including countries/economies targeted in the multi – country proposal |
|
Round 6 - November 2006
| Total | Total approved US$ 846 million in 63 countries | |
| By Region | East Asia & the Pacific - US$ 107 million in 8 countries |
|
| By Disease | HIV US$ 453 million in 34 countries
Malaria US$ 202 million in 19 countries Tuberculosis US$ 190 million in 34 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines |
|
Round 5 - September 2005
| Total | Total approved US$ 770 million in 60 countries | |
| By Region | East Asia & the Pacific - US$ 128 million in 17 countries |
|
| By Disease | HIV US$ 315 million in 25 countries
HSS US$ 38 million in 3 countries Malaria US$ 202 million in 26 countries Tuberculosis US$ 213 million in 23 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines |
|
Round 4 - June 2004
| Total | Total approved US$ 1,039 million in 52 countries | |
| By Region | Africa - US$ 663 million for 34 programs
in 23 countries Asia, Middle East & North Africa - US$237 million for 23 programs in 16 countries Latin America, Caribbean & Eastern Europe - US$ 139 million for 15 programs in 13 countries |
|
| By Disease | HIV US$ 469 m in 27 countries
Malaria US$ 417 m in 23 countries Tuberculosis US$ 153 m in 21 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines |
|
Round 3 - November 2003
| Total | US$ 623m for 71 programs in 61 countries | |
| By Region | Africa - US$ 365m for 34 programs in 23
countries Asia, Middle East & North Africa - US$ 127m for 15 programs in 13 countries Latin America, Caribbean & Eastern Europe - US$ 130m for 22 programs in 25 countries |
|
| By Disease | HIV US$ 362m for 31 programs in 52 countries HIV/TB US$ 27m for 2 programs in 2 countries Malaria US$ 166m for 20 programs in 20 countries Tuberculosis US$ 68m for 18 programs in 18 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines |
|
Round 2 - January 2003
| Total | US$ 866 million for 98 programs in 73 countries | |
| By Region | Africa - US$ 550m for 49 programs in 30
countries Asia, Middle East & North Africa - US$ 145m for 27 programs in 27 countries Latin America, Caribbean & Eastern Europe - US$ 171m for 22 programs in 16 countries |
|
| By Disease | HIV US$ 487m for 43 programs in 52 countries HIV/TB US$ 8m for 1 program in 1 country Integrated US$ 3m for 1 program in 1 country Malaria US$ 242m for 28 programs in 37 countries Tuberculosis US$ 126m for 25 programs in 35 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines |
|
Round 1 - April 2002
| Total | US$ 565 million for 55 programs in 36 countries | |
| By Region | Africa - US$ 308m for 27 programs in 16
countries Asia, Middle East & North Africa - US$ 151m for 18 programs in 11 countries Latin America, Caribbean & Eastern Europe - US$ 106m for 10 programs in 9 countries |
|
| By Disease | HIV US$ 326m for 26 programs in 22 countries HIV/TB US$ 55m for 4 programs in 3 countries Integrated US$ 20m for 1 program in 1 country Malaria US$ 68m for 12 programs in 12 countries Tuberculosis US$ 96m for 12 programs in 12 countries |
|
| Documentation | TRP Funding Recommendations | Full
List of Approved Proposals Guidelines |
|
Summary of RCC Wave 3 Funding Decisions July 2008
| Total | US $513,349,804 in eight countries | ||
| By Country | Bulgaria - US $28,021,697 |
||
| By Disease | HIV and AIDS - US $426,505,339 |
||
| Documentation |
|
Summary of RCC Wave 2 Funding Decisions April 2008
| Total | US $364,489,068 in five countries | ||
| By Country | Malawi - US $ 173,329,414 |
||
| By Disease | HIV and AIDS - US $ 232,968,175 |
||
| Documentation |
|
Summary of RCC Wave 1 Funding Decisions November 2007
| Total | US $129,713,262 in five countries | ||
| By Country | Burundi - US $19,694,151 |
||
| By Disease | HIV and AIDS - US $ 47,187,023 |
||
| Documentation |
|
